Question 1

Am I eligible to participate in this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer clinical trial (NCT02733107). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the combination of apatinib and etoposide compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer clinical trial (NCT02733107). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of these medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer clinical trial (NCT02733107). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer clinical trial (NCT02733107). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the treatment process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer clinical trial (NCT02733107). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any additional tests or procedures involved in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer clinical trial (NCT02733107). Contact the study team or your healthcare provider for specific answers.

What this study is about